AZYO insider filings

AZIYO BIOLOGICS, INC. — 49 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-23. Screen AZYO transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for AZYO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — AZIYO BIOLOGICS, INC.

FiledFormInsiderReported transactionsSource
2023-06-234Mills C Randal — PRESIDENT AND CEO, DirectorOption exercise (M): 22,474 · Tax withholding (F): 7,772 @ $2.41 · Option exercise (M): 22,474 (derivative) @ $0EDGAR
2023-06-124Colpman David — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-124Jordan Maybelle — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-124Makes Brigid — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-124HighCape Capital, L.P. — Director, 10% owner
HIGHCAPE PARTNERS, L.P. — Director, 10% owner
HIGHCAPE PARTNERS QP, L.P. — Director, 10% owner
HighCape Partners GP, LLC — Director, 10% owner
HighCape Partners GP, L.P. — Director, 10% owner
HighCape Co-Investment Vehicle I, LLC — Director, 10% owner
HighCape Co-Investment Vehicle II, LLC — Director, 10% owner
HighCape Capital, LLC — Director, 10% owner
Zuga Matt — Director, 10% owner
RAKIN KEVIN — Director, 10% owner
Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-04-284Mills C Randal — PRESIDENT AND CEO, DirectorOption exercise (M): 44,947 @ $0 · Grant/award (A): 134,840 (derivative) @ $0 · Option exercise (M): 44,947 (derivative) @ $0 · Grant/award (A): 89,894 (derivative) @ $0EDGAR
2023-03-274Birchview Capital, LP — 10% owner
Birchview Fund LLC — 10% owner
Strobeck Matthew — 10% owner
Purchase (P): 100,000 @ $1.49 · Purchase (P): 10,000 @ $1.49 · Purchase (P): 18,000 @ $1.35 · Purchase (P): 2,000 @ $1.35 · Purchase (P): 10,000 @ $1.59EDGAR
2023-03-094Englese Thomas — CHIEF COMMERCIAL OFFICEROption exercise (M): 937 @ $0 · Sale (S): 289 @ $4.30 · Option exercise (M): 937 (derivative) @ $0EDGAR
2023-03-094Ferguson Matthew — CHIEF FINANCIAL OFFICEROption exercise (M): 1,287 @ $0 · Option exercise (M): 1,287 (derivative) @ $0EDGAR
2023-02-134Birchview Capital, LP — 10% owner
Birchview Fund LLC — 10% owner
Strobeck Matthew — 10% owner
Purchase (P): 200 @ $5.96 · Purchase (P): 40,000 @ $4.75 · Purchase (P): 10,000 @ $3.58 · Purchase (P): 34,000 @ $3.58 · Purchase (P): 9,061 @ $3.79 · Purchase (P): 4,000 @ $3.79EDGAR
2022-12-284HighCape Partners GP II, LLC — 10% owner
HighCape Partners GP II, L.P. — 10% owner
HighCape Partners QP II, L.P. — 10% owner
HighCape Partners II, L.P. — 10% owner
Grant/award (A): 17,533 (derivative) @ $0EDGAR
2022-12-274HighCape Capital, L.P. — Director, 10% owner
HIGHCAPE PARTNERS, L.P. — 10% owner
HIGHCAPE PARTNERS QP, L.P. — 10% owner
HighCape Partners GP, LLC — 10% owner
HighCape Partners GP, L.P. — 10% owner
HighCape Co-Investment Vehicle I, LLC — 10% owner
HighCape Co-Investment Vehicle II, LLC — Director, 10% owner
HighCape Capital, LLC — 10% owner
Zuga Matt — Director, 10% owner
RAKIN KEVIN — Director, 10% owner
Grant/award (A): 17,533 (derivative) @ $0EDGAR
2022-12-164Colpman David — DirectorPurchase (P): 3,098 @ $3.90EDGAR
2022-12-124Makes Brigid — DirectorPurchase (P): 2,000 @ $3.65EDGAR
2022-12-074HighCape Capital, L.P. — Director, 10% owner
HIGHCAPE PARTNERS, L.P. — 10% owner
HIGHCAPE PARTNERS QP, L.P. — 10% owner
HighCape Partners GP, LLC — 10% owner
HighCape Partners GP, L.P. — 10% owner
HighCape Co-Investment Vehicle I, LLC — 10% owner
HighCape Co-Investment Vehicle II, LLC — 10% owner
HighCape Capital, LLC — 10% owner
Zuga Matt — Director, 10% owner
RAKIN KEVIN — Director, 10% owner
Purchase (P): 735,000 @ $4.75EDGAR
2022-12-054Ferguson Matthew — CHIEF FINANCIAL OFFICERPurchase (P): 6,000 @ $4.03 · Purchase (P): 20,000 @ $4.75 · Purchase (P): 2,000 @ $3.61EDGAR
2022-10-244Colpman David — DirectorGrant/award (A): 28,513 (derivative) @ $0EDGAR
2022-10-244Williams Michelle LeRoux — CHIEF SCIENTIFIC OFFICERGrant/award (A): 90,000 (derivative) @ $0EDGAR
2022-09-124Englese Thomas — CHIEF COMMERCIAL OFFICEROption exercise (M): 15,390 · Tax withholding (F): 4,728 @ $7.30 · Option exercise (M): 15,390 (derivative) @ $0EDGAR
2022-09-124Riebman Jerome — CHIEF MEDICAL OFFICEROption exercise (M): 14,758 · Tax withholding (F): 5,104 @ $7.30 · Option exercise (M): 14,758 (derivative) @ $0EDGAR
2022-09-124Edwards Peter G — GENERAL COUNSELOption exercise (M): 4,625 · Tax withholding (F): 1,127 @ $7.30 · Option exercise (M): 4,625 (derivative) @ $0EDGAR
2022-09-124Ferguson Matthew — CHIEF FINANCIAL OFFICEROption exercise (M): 13,874 · Tax withholding (F): 4,798 @ $7.30 · Option exercise (M): 13,874 (derivative) @ $0EDGAR
2022-06-234Mills C Randal — Interim President and CEO, DirectorGrant/award (A): 273,767 (derivative) @ $0 · Grant/award (A): 182,511 (derivative) @ $0EDGAR
2022-06-094Jordan Maybelle — DirectorGrant/award (A): 22,090 (derivative) @ $0EDGAR
2022-06-094Makes Brigid — DirectorGrant/award (A): 22,090 (derivative) @ $0EDGAR
2022-06-094Mills C Randal — DirectorGrant/award (A): 22,090 (derivative) @ $0EDGAR
2022-06-094HighCape Capital, L.P. — Director, 10% owner
HIGHCAPE PARTNERS, L.P. — 10% owner
HIGHCAPE PARTNERS QP, L.P. — 10% owner
HighCape Partners GP, LLC — 10% owner
HighCape Partners GP, L.P. — 10% owner
HighCape Co-Investment Vehicle I, LLC — 10% owner
HighCape Co-Investment Vehicle II, LLC — Director, 10% owner
HighCape Capital, LLC — 10% owner
Zuga Matt — Director, 10% owner
RAKIN KEVIN — Director, 10% owner
Grant/award (A): 22,090 (derivative) @ $0 · Grant/award (A): 22,090 (derivative) @ $0EDGAR
2022-03-104Englese Thomas — CHIEF COMMERCIAL OFFICEROption exercise (M): 938 @ $0 · Sale (S): 276 · Grant/award (A): 31,000 (derivative) @ $0 · Grant/award (A): 8,700 (derivative) @ $0 · Option exercise (M): 938 (derivative) @ $0 · Grant/award (A): 15,390 (derivative) @ $0EDGAR
2022-03-104Roberts Darryl — EVP, OPERATIONS & PRODUCT DEV.Option exercise (M): 938 @ $0 · Grant/award (A): 37,200 (derivative) @ $0 · Grant/award (A): 10,440 (derivative) @ $0 · Option exercise (M): 938 (derivative) @ $0 · Grant/award (A): 17,024 (derivative) @ $0EDGAR
2022-03-104Riebman Jerome — CHIEF MEDICAL OFFICEROption exercise (M): 782 @ $0 · Grant/award (A): 31,000 (derivative) @ $0 · Grant/award (A): 8,700 (derivative) @ $0 · Option exercise (M): 782 (derivative) @ $0 · Grant/award (A): 14,758 (derivative) @ $0EDGAR
2022-03-104LLOYD RONALD K. — PRESIDENT AND CEO, DirectorOption exercise (M): 4,072 @ $0 · Grant/award (A): 138,770 (derivative) @ $0 · Grant/award (A): 37,788 (derivative) @ $0 · Option exercise (M): 4,072 (derivative) @ $0 · Grant/award (A): 39,894 (derivative) @ $0EDGAR
2022-03-104Edwards Peter G — GENERAL COUNSELGrant/award (A): 31,000 (derivative) @ $0 · Grant/award (A): 8,700 (derivative) @ $0 · Grant/award (A): 4,625 (derivative) @ $0EDGAR
2022-03-104Ferguson Matthew — CHIEF FINANCIAL OFFICEROption exercise (M): 1,288 @ $0 · Grant/award (A): 31,000 (derivative) @ $0 · Grant/award (A): 8,700 (derivative) @ $0 · Option exercise (M): 1,288 (derivative) @ $0 · Grant/award (A): 13,874 (derivative) @ $0EDGAR
2021-12-154Englese Thomas — CHIEF COMMERCIAL OFFICERPurchase (P): 4,580 @ $6.10EDGAR
2021-12-104HighCape Capital, L.P. — Director, 10% owner
HIGHCAPE PARTNERS, L.P. — 10% owner
HIGHCAPE PARTNERS QP, L.P. — 10% owner
HighCape Partners GP, LLC — 10% owner
HighCape Partners GP, L.P. — 10% owner
HighCape Co-Investment Vehicle I, LLC — 10% owner
HighCape Co-Investment Vehicle II, LLC — 10% owner
HighCape Capital, LLC — 10% owner
Zuga Matt — Director, 10% owner
RAKIN KEVIN — Director, 10% owner
Purchase (P): 353,773 @ $4.24 · Purchase (P): 58,962 @ $4.24EDGAR
2021-09-014Edwards Peter G — GENERAL COUNSELGrant/award (A): 96,200 (derivative) @ $0EDGAR
2021-06-094Jordan Maybelle — DirectorGrant/award (A): 14,082 (derivative) @ $0EDGAR
2021-06-094Makes Brigid — DirectorGrant/award (A): 14,082 (derivative) @ $0EDGAR
2021-06-094Mills C Randal — DirectorGrant/award (A): 14,082 (derivative) @ $0EDGAR
2021-06-094HighCape Capital, L.P. — Director, 10% owner
HIGHCAPE PARTNERS, L.P. — 10% owner
HIGHCAPE PARTNERS QP, L.P. — 10% owner
HighCape Partners GP, LLC — 10% owner
HighCape Partners GP, L.P. — 10% owner
HighCape Co-Investment Vehicle I, LLC — 10% owner
HighCape Co-Investment Vehicle II, LLC — Director, 10% owner
HighCape Capital, LLC — 10% owner
Zuga Matt — Director, 10% owner
RAKIN KEVIN — Director, 10% owner
Grant/award (A): 14,082 (derivative) @ $0 · Grant/award (A): 14,082 (derivative) @ $0EDGAR
2021-05-124Ferguson Matthew — CHIEF FINANCIAL OFFICERPurchase (P): 1,300 @ $11.14 · Purchase (P): 1,000 @ $11EDGAR
2021-05-114LLOYD RONALD K. — PRESIDENT AND CEO, DirectorPurchase (P): 7,198 @ $11.65 · Purchase (P): 1,367 @ $12.28EDGAR
2020-10-134LLOYD RONALD K. — President and CEO, DirectorConversion (C): 14,586 @ $0 · Conversion (C): 111,788 (derivative) @ $0EDGAR
2020-10-134HighCape Capital, L.P. — 10% owner
HIGHCAPE PARTNERS, L.P. — 10% owner
HIGHCAPE PARTNERS QP, L.P. — 10% owner
HighCape Partners GP, LLC — 10% owner
HighCape Partners GP, L.P. — 10% owner
HighCape Co-Investment Vehicle I, LLC — 10% owner
HighCape Co-Investment Vehicle II, LLC — 10% owner
HighCape Capital, LLC — 10% owner
Zuga Matt — Director, 10% owner
RAKIN KEVIN — Director, 10% owner
Conversion (C): 4,062,451 @ $0 · Option exercise/expiry (X): 7,655 @ $5.44 · Tax withholding (F): 2,451 @ $5.44 · Purchase (P): 441,176 @ $17 · Conversion (C): 31,133,977 (derivative) @ $0 · Option exercise/expiry (X): 7,655 (derivative) @ $0EDGAR
2020-10-084Riebman Jerome — Chief Medical OfficerGrant/award (A): 30,412 (derivative) @ $0 · Grant/award (A): 10,186 (derivative) @ $0EDGAR
2020-10-084Englese Thomas — Chief Commercial OfficerGrant/award (A): 33,488 (derivative) @ $0 · Grant/award (A): 13,890 (derivative) @ $0EDGAR
2020-10-084Roberts Darryl — EVP, Operations & Product DeveGrant/award (A): 50,083 (derivative) @ $0 · Grant/award (A): 11,112 (derivative) @ $0EDGAR
2020-10-084LLOYD RONALD K. — President and CEO, DirectorGrant/award (A): 181,783 (derivative) @ $0 · Grant/award (A): 100,425 (derivative) @ $0EDGAR
2020-10-084Ferguson Matthew — Chief Financial OfficerGrant/award (A): 81,800 (derivative) @ $0EDGAR

Recent 8-K events — AZIYO BIOLOGICS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-218-K2.01 — Completion of Acquisition or Disposition of Assets
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-078-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-208-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-048-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AZYO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs